The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Dubinett Howard since 2006.
The trader's CIK number is 1189454.
At the time of the last reporting, Dubinett Howard was the Executive VP, COO of Bio Reference Laboratories Inc. (stock ticker symbol BRLI).
Also see all insider trading activities at Bio Reference Laboratories Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | BRLI | 0 | $0 | 20,000 | $588,020 | 0 | $0 |
| 2012 | BRLI | 0 | $0 | 10,000 | $296,620 | 0 | $0 |
| 2011 | BRLI | 10,000 | $142,400 | 20,000 | $474,709 | 0 | $0 |
| 2010 | BRLI | 0 | $0 | 55,000 | $1,456,470 | 0 | $0 |
| 2009 | BRLI | 0 | $0 | 85,803 | $2,572,373 | 0 | $0 |
| 2007 | BRLI | 0 | $0 | 79,644 | $1,374,655 | 0 | $0 |
| 2006 | BRLI | 0 | $0 | 90,485 | $1,297,554 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-09-13 | BRLI | Sale | 20,000 | 29.40 | 588,020 |
| 2012-12-18 | BRLI | Sale | 10,000 | 29.66 | 296,620 |
| 2011-12-12 | BRLI | Buy | 10,000 | 14.24 | 142,400 |
| 2011-04-26 | BRLI | Sale | 432 | 23.75 | 10,260 |
| 2011-04-27 | BRLI | Sale | 9,268 | 23.75 | 220,115 |
| 2011-04-21 | BRLI | Sale | 300 | 23.78 | 7,134 |
| 2011-01-14 | BRLI | Sale | 10,000 | 23.72 | 237,200 |
| 2010-10-15 | BRLI | Sale | 10,000 | 21.48 | 214,800 |
| 2010-09-27 | BRLI | Sale | 10,000 | 21.00 | 210,000 |
| 2010-06-11 | BRLI | Sale | 10,000 | 23.05 | 230,460 |
| 2010-06-14 | BRLI | Sale | 15,000 | 23.43 | 351,510 |
| 2010-03-11 | BRLI | Sale | 10,000 | 44.97 | 449,700 |
| 2009-10-19 | BRLI | Sale | 85,803 | 29.98 | 2,572,373 |
| 2007-09-28 | BRLI | Sale | 79,644 | 17.26 | 1,374,655 |
| 2006-03-30 | BRLI | Sale | 90,485 | 14.34 | 1,297,554 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dubinett Howard (Executive VP, COO of Bio Reference Laboratories Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.